Routine coagulation screening in the management of emergency admission for epistaxis--is it necessary?

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Cambridge University Press Country of Publication: England NLM ID: 8706896 Publication Model: Print Cited Medium: Print ISSN: 0022-2151 (Print) Linking ISSN: 00222151 NLM ISO Abbreviation: J Laryngol Otol Subsets: MEDLINE
    • Publication Information:
      Publication: Cambridge : Cambridge University Press
      Original Publication: London : Headley Brothers,
    • Subject Terms:
      Blood Coagulation Tests/*methods ; Epistaxis/*blood; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Blood Coagulation Tests/economics ; Child ; Emergency Treatment ; Epistaxis/etiology ; Epistaxis/therapy ; Female ; Hemostatics/administration & dosage ; Hemostatics/economics ; Humans ; Male ; Middle Aged ; Patient Admission ; Patient Readmission ; Retrospective Studies
    • Abstract:
      The role of routine coagulation studies in the management of patients suffering from epistaxis is unclear. In an attempt to address this issue the case notes of all emergency admissions for epistaxis to a large Scottish teaching hospital were retrospectively reviewed over a one-year period. One hundred and forty patients (63 male, 77 female) were admitted between January and December 1998. The patients who had coagulation studies were identified and their results analysed. A total of 121 patients (86.4 per cent) had coagulation studies performed. Of these, 10 (8.3 per cent) had abnormal results and all were taking warfarin or a combination of warfarin and aspirin. No other coagulation abnormalities were identified. This study supports the view that there does not appear to be a role for routine coagulation studies in patients admitted with epistaxis. The investigation for potential haemostatic disorders should be performed when clinically indicated and, if necessary, in consultation with the haematology service.
    • Accession Number:
      0 (Hemostatics)
    • Publication Date:
      Date Created: 20000502 Date Completed: 20000524 Latest Revision: 20190724
    • Publication Date:
      20240829
    • Accession Number:
      10.1258/0022215001903861
    • Accession Number:
      10789409